Maxim Affirms BiolineRx (BLRX) at 'Buy'; BL-8040 Should be Focus for Immune Oncology Segment

Go back to Maxim Affirms BiolineRx (BLRX) at 'Buy'; BL-8040 Should be Focus for Immune Oncology Segment
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.11 +0.05 (2.43%)
Previous Close $2.06    52 Week High $1.63 
Open $2.04    52 Week Low $0.71 
Day High $2.11    P/E N/A 
Day Low $2.04    EPS $0.00 
Volume 864       

BLUEBIRD BIO (NASDAQ: BLUE) Delayed: 4.97 --0 (-0%)
Previous Close $4.97    52 Week High $95.28 
Open $4.97    52 Week Low $35.37 
Day High $4.97    P/E N/A 
Day Low $4.97    EPS $-1.81 
Volume 4,278       

(NASDAQ: CLLS) Delayed: 0.99 +0.01 (1.02%)
Previous Close $0.98    52 Week High $37.55 
Open $1.00    52 Week Low $16.35 
Day High $1.02    P/E N/A 
Day Low $0.99    EPS $0.00 
Volume 8,156       

(NASDAQ: CYAD) Delayed: 0.47 --0 (-0%)
Previous Close $0.47    52 Week High $59.50 
Open $84.12    52 Week Low $16.31 
Day High $0.47    P/E N/A 
Day Low $0.47    EPS $0.00 
Volume 925,927       

(NASDAQ: JUNO) Delayed: 86.96 --0 (-0%)
Previous Close $86.96    52 Week High $57.82 
Open $10.20    52 Week Low $22.37 
Day High $86.96    P/E N/A 
Day Low $86.96    EPS $0.00 
Volume 1       

(NASDAQ: KITE) Delayed: 179.79 --0 (-0%)
Previous Close $179.79    52 Week High $89.84 
Open $17.44    52 Week Low $38.41 
Day High $179.79    P/E N/A 
Day Low $179.79    EPS $0.00 
Volume 146,685